Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ETS2 anticorps (Center)

ETS2 Reactivité: Humain, Rat WB, IF, IHC (p), IP, ChIP, ICC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN2855845
  • Antigène Voir toutes ETS2 Anticorps
    ETS2 (V-Ets Erythroblastosis Virus E26 Oncogene Homolog 2 (ETS2))
    Épitope
    • 9
    • 7
    • 7
    • 6
    • 6
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Center
    Reactivité
    • 46
    • 10
    • 8
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain, Rat
    Hôte
    • 41
    • 6
    Lapin
    Clonalité
    • 44
    • 3
    Polyclonal
    Conjugué
    • 27
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp ETS2 est non-conjugé
    Application
    • 35
    • 22
    • 16
    • 15
    • 5
    • 5
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Chromatin Immunoprecipitation (ChIP), Immunocytochemistry (ICC)
    Attributs du produit
    Rabbit Polyclonal antibody to ETS2 (v-ets erythroblastosis virus E26 oncogene homolog 2 (avian))
    ETS2 antibody
    Purification
    Purified by antigen-affinity chromatography.
    Immunogène
    Recombinant protein encompassing a sequence within the center region of human ETS2. The exact sequence is proprietary.
    Isotype
    IgG
  • Indications d'application
    Suggested dilution Reference ChIP assay Assay-dependent dilution ICC/IF 1:100-1:1000* IHC (Formalin-fixed paraffin-embedded sections) 1:100-1:1000* Immunoprecipitation 1:100-1:500* Western blot 1:500-1:3000* Not tested in other applications. *Optimal dilutions/concentrations should be determined by the researcher.Suggested dilutionReferenceChIP assayAssay-dependent dilution ICC/IF1:100-1:1000* IHC (Formalin-fixed paraffin-embedded sections)1:100-1:1000* Immunoprecipitation1:100-1:500* Western blot1:500-1:3000*
    Commentaires

    Positive Control: HeLa

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 mg/mL
    Buffer
    1XPBS, 1 % BSA, 20 % Glycerol ( pH 7). 0.01 % Thimerosal was added as a preservative.
    Agent conservateur
    Thimerosal (Merthiolate)
    Précaution d'utilisation
    This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
  • Gluck, Glathar, Tsompana, Nowak, Garrett-Sinha, Buck, Sinha: "Molecular dissection of the oncogenic role of ETS1 in the mesenchymal subtypes of head and neck squamous cell carcinoma." dans: PLoS genetics, Vol. 15, Issue 7, pp. e1008250, (2019) (PubMed).

    Yuan, Jiang, Mayakonda, Huang, Ding, Lin, Yu, Lu, Loh, Chow, Savage, Tyner, Lin, Koeffler: "Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma." dans: Cancer research, Vol. 77, Issue 23, pp. 6614-6626, (2018) (PubMed).

    Helbig, Wockner, Bouendeu, Hille-Betz, McCue, French, Edwards, Pickett, Reddel, Chenevix-Trench, Dörk, Beesley: "Functional dissection of breast cancer risk-associated TERT promoter variants." dans: Oncotarget, Vol. 8, Issue 40, pp. 67203-67217, (2017) (PubMed).

  • Antigène
    ETS2 (V-Ets Erythroblastosis Virus E26 Oncogene Homolog 2 (ETS2))
    Autre désignation
    ETS2 (ETS2 Produits)
    Synonymes
    anticorps 0123/09, anticorps 0608/07, anticorps 0998/12, anticorps 3520, anticorps CG17077, anticorps CG8705, anticorps D-Ets-2, anticorps D-ets-2, anticorps DMPOINT1A, anticorps Dmel\\CG17077, anticorps E(E2F)3D, anticorps EK3-2, anticorps ETS2, anticorps EY3-1, anticorps Ets, anticorps Ets2, anticorps Ets58AB, anticorps Ets94F, anticorps PNT-P1, anticorps PNTP1, anticorps PNTP2, anticorps POINT, anticorps Pnt, anticorps Pnt-P1, anticorps PntP1, anticorps PntP2, anticorps Pointed-P1, anticorps ets94F, anticorps l(3)07825, anticorps l(3)j1B7, anticorps l(3)s118306, anticorps png, anticorps pnt-P1, anticorps pnt-P2, anticorps pntP2, anticorps pntegfr, anticorps pointed-RC, anticorps ptd, anticorps zgc:92106, anticorps wu:fe02h08, anticorps wu:fk74c05, anticorps AU022856, anticorps Ets-2, anticorps ETS2IT1, anticorps c-ets-2, anticorps pointed, anticorps v-ets avian erythroblastosis virus E26 oncogene homolog 2, anticorps E26 avian leukemia oncogene 2, 3' domain, anticorps ETS proto-oncogene 2, transcription factor, anticorps pnt, anticorps ets2, anticorps Ets2, anticorps ETS2
    Sujet
    ETS transcriptions factors, such as ETS2, regulate numerous genes and are involved in stem cell development, cell senescence and death, and tumorigenesis. The conserved ETS domain within these proteins is a winged helix-turn-helix DNA-binding domain that recognizes the core consensus DNA sequence GGAA/T of target genes (Dwyer et al., 2007 [PubMed 17986575]).[supplied by OMIM]

    Cellular Localization: Nucleus
    Poids moléculaire
    53 kDa
    ID gène
    2114
    Pathways
    EGFR Signaling Pathway, Myometrial Relaxation and Contraction
Vous êtes ici:
Support technique